Benchmark Investments

Home Insights MF Screener Fund Card

Fund Card

Tata India Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care

31.07 -0.33(-1.04%) NAV as on 18 Sep 2024

4.66 % 1 M

53.11 % 1 Y

19.67 % 3 Y

Growth Chart of the Scheme vis a vis benchmark

SCHEME DETAILS

Expenses Ratio :

2.14

As on 31 Aug, 2024

Age :

8 yrs 8 m

Since 28 12 ,2015

Exit Load :

0.25%

AUM :

1,183.18 Crs

Portfolio Price To Book Value :

6.71

Investing Style :

Large Growth

Min. Investment :

SIP 100 & Lumpsum 5000

Category :

sector funds

Fund Manager :

Meeta Shetty

Launch Date :

28-Dec-15

Scheme Benchmark :

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

LATEST ASSET & PORTFOLIO ALLOCATION

as on Aug 31 ,2024

Others 6.87 %

Equity 93.13 %

TOP HOLDINGS

Sun Pharmaceutical Industries...12.38 %

Aurobindo Pharma Ltd.9.83 %

Lupin Ltd.7.77 %

Dr. Reddy's Laboratories Ltd.7.30 %

Cipla Ltd.6.85 %

See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs	76.95
Hospital & Healthcare Services	11.40
Business Support	2.87
Fertilizers	0.89
Trading	0.58

See All Sectors

5-YEARS HISTORY

Financial Year	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
NAV in Rs (as on 31-Mar-2024)	8.93	14.73	17.18	15.88	25.06
Net Assets(Rs Crores) (as on 31-Mar-2024)	152.64	435.03	553.33	493.44	878.70
Scheme Returns(%)(Absolute)	-2.19	67.24	16.04	-7.31	57.46
B'mark Returns(%)(Absolute)	NA	NA	NA	NA	NA
Category Rank	11/75	49/75	41/75	67/76	19/90

Quarterly Performance - Last 5 Years (Absolute Ret. In %)

Financial Year	Q1	Q2	Q3	Q4
2024-2025	4.62	NA	NA	NA
2023-2024	15.19	11.11	11.38	10.75
2022-2023	-10.36	8.14	-0.52	-4.19
2021-2022	16.84	3.71	0.97	-4.64
2020-2021	25.07	21.78	11.24	-2.68

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity31.07-0.33(-1.04%)NAV As on 19 Sep, 2024	28-Dec-2015Inception Date	1,183.18AUM In Cr.	53.11%1Y	19.67%3Y	28.30%5Y	13.86%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity38.44-0.28(-0.72%)NAV As on 19 Sep, 2024	13-Jul-2018Inception Date	4,807.86AUM In Cr.	57.99%1Y	21.59%3Y	32.21%5Y	24.29%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity415.89-3.93(-0.94%)NAV As on 19 Sep, 2024	14-Jul-1999Inception Date	3,202.66AUM In Cr.	47.92%1Y	20.76%3Y	30.01%5Y	16.70%Since Inception
DSP Healthcare Fund-Reg(G)Very HighEquity40.40-0.20(-0.50%)NAV As on 19 Sep, 2024	30-Nov-2018Inception Date	2,934.17AUM In Cr.	53.25%1Y	19.29%3Y	31.96%5Y	27.19%Since Inception
UTI Healthcare Fund-Reg(G)Very HighEquity284.64-0.70(-0.25%)NAV As on 19 Sep, 2024	01-Aug-2005Inception Date	1,167.75AUM In Cr.	53.85%1Y	18.30%3Y	29.36%5Y	19.11%Since Inception
Nippon India Pharma Fund(G)Very HighEquity517.97-5.90(-1.13%)NAV As on 19 Sep, 2024	05-Jun-2004Inception Date	8,647.95AUM In Cr.	46.95%1Y	18.14%3Y	29.59%5Y	21.46%Since Inception